Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III.

Child development Developmental disabilities Language development disorders Motor skills disorders Neurodevelopmental disorders

Journal

Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 26 12 2020
pubmed: 1 2 2021
medline: 25 2 2023
entrez: 31 1 2021
Statut: ppublish

Résumé

We describe the development of 236 children with Angelman syndrome (AS) using the Bayley Scales of Infant and Toddler Development, Third Edition. Multilevel linear mixed modeling approaches were used to explore differences between molecular subtypes and over time. Individuals with AS continue to make slow gains in development through at least age 12 years of age at about 1-2 months/year based on age equivalent score and 1-16 growth score points/year depending on molecular subtype and domain. Children with a deletion have lower scores at baseline and slower rate of gaining skills while children with UBE3A variant subtype demonstrated higher scores as well as greater rates of skill attainment in all domains. The developmental profiles of UPD and ImpD were similar.

Identifiants

pubmed: 33517526
doi: 10.1007/s10803-020-04861-1
pii: 10.1007/s10803-020-04861-1
pmc: PMC8322148
mid: NIHMS1686845
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

720-737

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD103537
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD061222
Pays : United States
Organisme : NCRR NIH HHS
ID : U54 RR019478
Pays : United States
Organisme : NIH HHS
ID : U54 RR019478
Pays : United States
Organisme : National Institutes of Health
ID : U54 RR019478
Organisme : National Institute of Child Health and Human Development
ID : U54 HD061222

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Références

Mol Syndromol. 2012 Apr;2(3-5):100-112
pubmed: 22670133
Clin Genet. 2004 Dec;66(6):530-6
pubmed: 15521981
Am J Intellect Dev Disabil. 2020 Nov 1;125(6):475-480
pubmed: 33211814
PLoS One. 2020 Apr 29;15(4):e0231317
pubmed: 32348359
Ital J Pediatr. 2016 Oct 21;42(1):91
pubmed: 27769316
Am J Speech Lang Pathol. 2017 May 17;26(2):369-382
pubmed: 28384804
J Dev Behav Pediatr. 2010 Sep;31(7):592-601
pubmed: 20729760
Am J Med Genet A. 2020 Jan;182(1):53-63
pubmed: 31729827
Psychiatry Res. 2011 Oct 30;189(3):440-5
pubmed: 21507490
J Med Genet. 2003 Feb;40(2):87-95
pubmed: 12566516
J Intellect Disabil Res. 2010 Nov;54(11):1024-9
pubmed: 20854288
J Med Genet. 2001 Dec;38(12):834-45
pubmed: 11748306
J Intellect Disabil Res. 2019 Oct;63(10):1234-1247
pubmed: 31134691
Am J Med Genet A. 2018 May;176(5):1099-1107
pubmed: 28944563
Dev Med Child Neurol. 2019 Nov;61(11):1266-1274
pubmed: 31074506
BMC Neurol. 2014 Dec 10;14:232
pubmed: 25491305
J Dev Behav Pediatr. 2014 Nov-Dec;35(9):570-5
pubmed: 25370298
Logoped Phoniatr Vocol. 2001;26(1):2-9
pubmed: 11432411
Paediatr Drugs. 2003;5(10):647-61
pubmed: 14510623
Epilepsy Behav. 2016 Jul;60:138-141
pubmed: 27206232
Am J Med Genet A. 2015 Nov;167A(11):2623-8
pubmed: 26219744
J Child Psychol Psychiatry. 2012 Feb;53(2):152-9
pubmed: 21831244
Am J Med Genet. 1995 Mar 27;56(2):176-83
pubmed: 7625442
Eur J Hum Genet. 2004 Dec;12(12):987-92
pubmed: 15470370
Appl Clin Genet. 2014 May 16;7:93-104
pubmed: 24876791
Am J Med Genet A. 2006 Sep 15;140(18):1936-43
pubmed: 16906556
Am J Med Genet A. 2018 Jul;176(7):1641-1647
pubmed: 29737008
Am J Med Genet A. 2013 Sep;161A(9):2197-203
pubmed: 23913711
Eur J Hum Genet. 2019 Nov;27(11):1649-1658
pubmed: 31186545
Am J Med Genet A. 2006 Mar 1;140(5):413-8
pubmed: 16470747
Ment Retard Dev Disabil Res Rev. 2005;11(3):197-208
pubmed: 16161087
J Med Genet. 2006 Jun;43(6):512-6
pubmed: 16183798
Cell Mol Life Sci. 2007 Apr;64(7-8):947-60
pubmed: 17347796
Am J Med Genet A. 2011 Jan;155A(1):81-90
pubmed: 21204213
Eur J Med Genet. 2016 Jun;59(6-7):315-9
pubmed: 27174604
Res Dev Disabil. 2014 Jul;35(7):1742-7
pubmed: 24656292
J Pediatr Rehabil Med. 2010;3(4):319-29
pubmed: 21791866

Auteurs

Anjali Sadhwani (A)

Department of Psychiatry, Boston Children's Hospital, Boston, MA, 02115, USA. Anjali.sadhwani@childrens.harvard.edu.
Harvard Medical School, Boston, MA, USA. Anjali.sadhwani@childrens.harvard.edu.

Anne Wheeler (A)

RTI International, Research Triangle Park, NC, USA.

Angela Gwaltney (A)

RTI International, Research Triangle Park, NC, USA.

Sarika U Peters (SU)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.

Rene L Barbieri-Welge (RL)

Developmental Evaluation Clinic, Rady Children's Hospital - San Diego, San Diego, CA, USA.

Lucia T Horowitz (LT)

Greenwood Genetic Center, Greenwood, SC, USA.

Lisa M Noll (LM)

Psychology Service, Texas Children's Hospital, Houston, TX, USA.
Baylor College of Medicine, Houston, TX, USA.

Rachel J Hundley (RJ)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.

Lynne M Bird (LM)

Division of Dysmorphology/Genetics, Rady Children's Hospital - San Diego, San Diego, CA, USA.
Department of Pediatrics, University of California, San Diego, San Diego, CA, USA.

Wen-Hann Tan (WH)

Harvard Medical School, Boston, MA, USA.
Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH